HFEA Statement on licensing of applications to carry out research using human-animal cytoplasmic hybrid embryos
17 January 2008
An HFEA Licence Committee has considered two applications, from Kings College London and Newcastle University, to carry out research using human-animal cytoplasmic hybrid embryos.
The members of the Licence Committee considered the applications at their meetings of 28 November 2007 and 9 January 2008.
The HFEA Licence Committee determined that the two applications satisfied all the requirements of the law and has now offered one-year research licences to the two applicants, subject to a series of detailed conditions in each case.
Details of the decision and the conditions can be found in the minutes of the Committee's deliberations.
Ends
Download the Licence Committee minutes:
- HFEA Licence Committee minutes for R0179 Newcastle (84kb)
November 2007 and January 2008 - HFEA Licence Committee minutes for R0180 Kings (88kb)
November 2007 and January 2008
More information:
Notes to editors
The HFEA is the independent regulator for IVF treatment and embryo research. Our role is to protect patients and the public interest, to drive improvement in the treatment and research sectors and to provide information to the public and policymakers about treatment and research.
The HFEA was set up in August 1991 as part of the Human Fertilisation and Embryology Act 1990. The HFEA's principal tasks are to license and monitor clinics that carry out in vitro fertilisation (IVF), donor insemination (DI) and human embryo research. The HFEA also regulates the storage of gametes (eggs and sperm) and embryos.
For further information please contact the HFEA press office.
Contact the press office
HFEA Press Office
Tel: 020 7291 8226
Email: press.office@hfea.gov.uk
Out of hours urgent press contact: 07771 981 920 (for media enquiries only.)
Page last updated: 18 March 2009
The creation human/animal embryos for research comes with many ethical and social implications.
Find out about human embryo research taking place throughout the UK - including human-animal hybrids and stem cell reseach.